The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(5-((9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methylthio)-1,3,4-thiadiazol-2-yl)-3-phenylurea ID: ALA4580964
PubChem CID: 50802359
Max Phase: Preclinical
Molecular Formula: C19H16N6O2S2
Molecular Weight: 424.51
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccn2c(=O)cc(CSc3nnc(NC(=O)Nc4ccccc4)s3)nc12
Standard InChI: InChI=1S/C19H16N6O2S2/c1-12-6-5-9-25-15(26)10-14(20-16(12)25)11-28-19-24-23-18(29-19)22-17(27)21-13-7-3-2-4-8-13/h2-10H,11H2,1H3,(H2,21,22,23,27)
Standard InChI Key: JKKIVGWPXPKHDX-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
2.6318 -7.3671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6306 -8.1866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3387 -8.5956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0483 -8.1861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0455 -7.3635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3369 -6.9582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7567 -8.5936 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4637 -8.1839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1721 -8.5914 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4625 -7.3667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8791 -8.1817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6236 -8.5099 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1695 -7.9018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7598 -7.1947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9607 -7.3659 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.0909 -6.4476 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.9035 -6.3608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2346 -5.6137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0481 -5.5317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3792 -4.7854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7537 -4.9604 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0812 -4.2139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8952 -4.1275 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2257 -3.3807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7433 -2.7196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9266 -2.8103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5998 -3.5574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1916 -4.6971 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7876 -3.6472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
9 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 11 1 0
14 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 23 1 0
22 21 2 0
21 18 1 0
22 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
20 28 2 0
27 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 424.51Molecular Weight (Monoisotopic): 424.0776AlogP: 3.79#Rotatable Bonds: 5Polar Surface Area: 101.28Molecular Species: ACIDHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.37CX Basic pKa: 0.85CX LogP: 3.24CX LogD: 2.36Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.37Np Likeness Score: -2.86
References 1. Subramanian G, Zhu Y, Bowen SJ, Roush N, White JA, Huczek D, Zachary T, Javens C, Williams T, Janssen A, Gonzales A.. (2019) Lead identification and characterization of hTrkA type 2 inhibitors., 29 (22): [PMID:31610943 ] [10.1016/j.bmcl.2019.126680 ]